Segment disclosures

Company overview

GEN PROBE INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 3 retained observations 3 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Novartis

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=gpro:NovartisMember
PeriodValueUnitFiledEvidence
2011-01-01 – 2011-12-31209323000 USD20120223Open filing evidence
2010-01-01 – 2010-12-31219457000 USD20120223Open filing evidence
2009-01-01 – 2009-12-31208450000 USD20120223Open filing evidence